Inventor · disambiguated record
Ann Maclaren
Also filed as: MACLAREN ANN
1 granted patent·3 pending applications·0 citations·filing 2008–2020
14Inventor score
Files withBIOGEN IDEC INC1CELGENE INT II SARL1CELGENE TRI A HOLDINGS LTD1TRIPHASE ACCELERATOR U S CORP1
Top patents by PatentIndex Score
4 records- 0160US11980606B2Use of marizomib for the treatment of central nervous system (CNS) cancersCELGENE INT II SARL·Filed 2020·Granted May 14, 2024·0 cites·8 claims
- 0257US2009155255A1Cd23 binding molecules and methods of use thereofBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 0338US2017348284A1Use of marizomib for the treatment of central nervous system (cns) cancersCELGENE TRI A HOLDINGS LTD·Filed 2017·Application pending·0 cites
- 0426US2019201541A1Anti-cd22 antibody-maytansine conjugates, combinations, and methods of use thereofTRIPHASE ACCELERATOR U S CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ann Maclaren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →